Eupraxia Pharmaceuticals Inc. Common Stock (EPRX)
Eupraxia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for neurodegenerative and neurological disorders. The company emphasizes the advancement of drug candidates that target unmet medical needs through novel delivery platforms and formulations.
Company News
Eupraxia Pharmaceuticals announced the results of its Annual General and Special Meeting of Shareholders, where all six proposed directors were elected, and other business items were approved by shareholders.
Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of NEXLETOL® tablets in diverse populations. Esperion Therapeutics shares climbed 7.1% to $3.47 pre-market trading. Here are some other stocks moving ...